Sort
30,917 grants matching “tumor microenvironment”
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis
$403,939Zena Werb · University Of California, San Francisco · R01 · FY2015 · CA
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis
$403,939Zena Werb · University Of California, San Francisco · R01 · FY2016 · CA
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
$403,928Atsuo Sasaki · University Of Cincinnati · R01 · FY2022 · CA
Pregnancy, Obesogenic Environments, and Basal-like Breast Cancer
$403,921Melissa A. Troester · Univ Of North Carolina Chapel Hill · U01 · FY2013 · ES
Control of the immune response for cancer vaccine development
$403,882Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Role of Inflammation in Tax-mediated Tumorigenesis
$403,821Lee Ratner · Ohio State University · P01 · FY2011 · CA
Data Generation
$403,759James Korkola · Oregon Health & Science University · U54 · FY2014 · HG
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2023 · NS
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2025 · NS
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2022 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$403,749Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2017 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$403,749Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2018 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$403,749Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2016 · NS
Three-dimensional organoid models to study breast cancer progression
$403,713Shilpa Sant · University Of Illinois At Chicago · R37 · FY2024 · CA
TlBr Detectors for High Resolution PET Imaging
$403,711Gregory Scott Mitchell · University Of California At Davis · R01 · FY2018 · CA
Phospholipase D1 and pancreatic cancer
$403,688Gerardo Guillermo Mackenzie · University Of California At Davis · R21 · FY2020 · CA
Develop universal CAR macrophage cell therapy for pancreatic cancer
$403,687Pingping Hou · Rutgers Biomedical And Health Sciences · R21 · FY2024 · CA
Phage-based therapeutic gene delivery targeting multiple compartments in solid tumors
$403,686Renata Pasqualini · Rutgers Biomedical And Health Sciences · R21 · FY2024 · CA
Sex specific epigenetic regulation of colon cancer metastasis
$403,649Y. Alan Wang · Indiana University Indianapolis · R01 · FY2022 · CA
Immune Aging in Responsiveness to Checkpoint Blockade Immunotherapies
$403,645Vandana Kalia · Seattle Children'S Hospital · R56 · FY2022 · AG
NK cell exhaustion in metastatic melanoma
$403,630Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Deciphering MDSC function for GBM targeting
$403,517Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · NS
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$403,487John H Sampson · Duke University · R01 · FY2016 · NS
Development of new Pt-based ROS storm inducing polymers with tumor specific toxicity
$403,485Junhua Mai · Methodist Hospital Research Institute · R21 · FY2025 · CA
Genetic requirements of Helicobacter pylori infection
$403,430Nina Reda Salama · Fred Hutchinson Cancer Center · R01 · FY2022 · AI